Cargando…

Inhibition of Lymphangiogenesis of Endothelial Progenitor Cells with VEGFR-3 siRNA Delivered with PEI-alginate Nanoparticles

Lymphangiogenesis is implicated in lymphatic metastasis of tumor cells. Recently, growing evidences show that endothelial progenitor cells (EPCs) are involved in lymphangiogenesis. This study has investigated effects of VEGF-C/VEGFR-3 (vascular endothelial growth factor receptor-3) signaling pathway...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ting, Wang, Guo-dong, Tan, Yu-zhen, Wang, Hai-jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920171/ https://www.ncbi.nlm.nih.gov/pubmed/24520214 http://dx.doi.org/10.7150/ijbs.6719

Ejemplares similares

Enhancement of cardiac lymphangiogenesis by transplantation of CD34(+)VEGFR-3(+) endothelial progenitor cells and sustained release of VEGF-C
por: Zhang, Hai-feng, et al.
Publicado: (2019)

Autophagy promotes degradation of polyethyleneimine–alginate nanoparticles in endothelial progenitor cells
por: Wang, Guo-dong, et al.
Publicado: (2017)

Fluorinated PEG-PEI Coated Magnetic Nanoparticles for siRNA Delivery and CXCR4 Knockdown
por: Cao, Yixiang, et al.
Publicado: (2022)

Nischarin-siRNA delivered by polyethylenimine-alginate nanoparticles accelerates motor function recovery after spinal cord injury
por: Ding, Yue-min, et al.
Publicado: (2017)

Antiproliferative activity of CD44 siRNA-PEI-PEG nanoparticles in glioblastoma: involvement of AKT signaling
por: Mahinfar, Parvaneh, et al.
Publicado: (2021)

Retrovirus-delivered siRNA
por: Devroe, Eric, et al.
Publicado: (2002)

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
por: Höbel, Sabrina, et al.
Publicado: (2011)

Novel PEI/Poly-γ-Gutamic Acid Nanoparticles for High Efficient siRNA and Plasmid DNA Co-Delivery
por: Peng, Shu-Fen, et al.
Publicado: (2017)

PEI-Coated Fe(3)O(4) Nanoparticles Enable Efficient Delivery of Therapeutic siRNA Targeting REST into Glioblastoma Cells
por: Wang, Rui, et al.
Publicado: (2018)

Plasma polymerized nanoparticles effectively deliver dual siRNA and drug therapy in vivo
por: Michael, Praveesuda, et al.
Publicado: (2020)

Voltage Preconditioning Allows Modulated Gene Expression in Neurons Using PEI-complexed siRNA
por: Sridharan, Arati, et al.
Publicado: (2013)

CD34(+)VEGFR-3(+) progenitor cells have a potential to differentiate towards lymphatic endothelial cells
por: Tan, Yu-zhen, et al.
Publicado: (2014)

Novel Fluorinated Spermine and Small Molecule PEI to Deliver Anti-PD-L1 and Anti-VEGF siRNA for Highly Efficient Tumor Therapy
por: Zhang, Yihui, et al.
Publicado: (2021)

CS-PEI/Beclin-siRNA Downregulate Multidrug Resistance Proteins and Increase Paclitaxel Therapeutic Efficacy against NSCLC
por: Liu, Wangta, et al.
Publicado: (2019)

Regulation of lymphangiogenesis in the diaphragm by macrophages and VEGFR-3 signaling
por: Ochsenbein, Alexandra M., et al.
Publicado: (2016)

Functionalized Folate-Modified Graphene Oxide/PEI siRNA Nanocomplexes for Targeted Ovarian Cancer Gene Therapy
por: Wang, Yunfei, et al.
Publicado: (2020)

Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery
por: Prabhakar, Neeraj, et al.
Publicado: (2016)

Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma
por: Tong, Wing Yin, et al.
Publicado: (2018)

MMP-2 Silencing through siRNA Loaded Positively-Charged Nanoparticles (AcPEI-NPs) Counteracts Chondrocyte De-Differentiation
por: Conte, Raffaele, et al.
Publicado: (2023)

Polyethyleneimine (PEI) Mediated siRNA Gene Silencing in the Schistosoma mansoni Snail Host, Biomphalaria glabrata
por: Knight, Matty, et al.
Publicado: (2011)

PAMAM versus PEI complexation for siRNA delivery: interaction with model lipid membranes and cellular uptake
por: Chang, Patrick K. C., et al.
Publicado: (2022)

Recent Advances in Mesoporous Silica Nanoparticles Delivering siRNA for Cancer Treatment
por: Xie, Xiaowei, et al.
Publicado: (2023)

PinX1-siRNA/mPEG-PEI-SPION combined with doxorubicin enhances the inhibition of glioma growth
por: LONG, LING, et al.
Publicado: (2014)

Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells
por: Yang, Yazong, et al.
Publicado: (2016)

Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multi-drug resistant tumors
por: Essex, Sean, et al.
Publicado: (2014)

Tyrosine-Modification of Polypropylenimine (PPI) and Polyethylenimine (PEI) Strongly Improves Efficacy of siRNA-Mediated Gene Knockdown
por: Noske, Sandra, et al.
Publicado: (2020)

Macrophage-Mediated Lymphangiogenesis: The Emerging Role of Macrophages as Lymphatic Endothelial Progenitors
por: Ran, Sophia, et al.
Publicado: (2012)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

Folate-targeted selenium nanoparticles deliver therapeutic siRNA to improve hepatocellular carcinoma therapy
por: Xia, Yu, et al.
Publicado: (2018)

Liver-Targeted Combination Therapy Basing on Glycyrrhizic Acid-Modified DSPE-PEG-PEI Nanoparticles for Co-delivery of Doxorubicin and Bcl-2 siRNA
por: Tian, Guixiang, et al.
Publicado: (2019)

Sustained delivery of siRNA/PEI complex from in situ forming hydrogels potently inhibits the proliferation of gastric cancer
por: Peng, Hao, et al.
Publicado: (2016)

Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation
por: Zhao, Meng-Dan, et al.
Publicado: (2016)

In Vitro and In Vivo Assessment of PEGylated PEI for Anti-IL-8/CxCL-1 siRNA Delivery to the Lungs
por: Hibbitts, Alan J., et al.
Publicado: (2020)

Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation
por: Huggenberger, Reto, et al.
Publicado: (2010)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Expression of VEGFR-3 in intrahepatic cholangiocarcinoma correlates with unfavorable prognosis through lymphangiogenesis
por: Sha, Meng, et al.
Publicado: (2018)

Self-assembled nanoparticles based on the c(RGDfk) peptide for the delivery of siRNA targeting the VEGFR2 gene for tumor therapy
por: Liu, Li, et al.
Publicado: (2014)

Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA
por: Zhang, Haiyang, et al.
Publicado: (2018)

Inhibition of AGS Cancer Cell Proliferation following siRNA-Mediated Downregulation of VEGFR2
por: Zarei Mahmudabadi, Ali, et al.
Publicado: (2016)

Matrix metalloproteinase 14 participates in corneal lymphangiogenesis through the VEGF-C/VEGFR-3 signaling pathway
por: Du, Hai-Tao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kvfpg0orq9lrmnhs5ghseuced1